TD Cowen Upgrades Genmab to Buy, Raises Price Target to $43
Genmab A/S
Genmab A/S GMAB | 0.00 |
TD Cowen analyst Yaron Werber upgrades Genmab (NASDAQ:
GMAB) from Hold to Buy and raises the price target from $32 to $43.
TD Cowen Upgrades Genmab to Buy, Raises Price Target to $43
Genmab A/S GMAB | 0.00 |